Skip to main content

Table 3 Adverse events associated with FLV and FLV+TJ-43 treatment.

From: Rikkunshi-to attenuates adverse gastrointestinal symptoms induced by fluvoxamine

 

FLV

FLV+TJ-43

 

Adverse events

Number (%) of patients reporting event

 

GI symptoms

   

   Nausea

9 (36)

3 (12)

*

   Anorexia

3 (12)

3 (12)

 

   Abdominal fullness

1 (4)

0 (0)

 

   Constipation

1 (4)

0 (0)

 

   Diarrhea

1 (4)

0 (0)

 

Feel discomfort

3 (12)

2 (8)

 

Feel irritable

1 (4)

0 (0)

 

Difficulty in urinating

1 (4)

0 (0)

 

General fatigue

1 (4)

0 (0)

 

Tremor

0 (0)

1 (4)

 
 

/25

/25

 
  1. FLV = fluvoxamine; TJ-43 = Rikkunshito; GI:gastrointestinal. * p < 0.05 by Fisher exact probability test.